R&D + Strategic Partnering For The
Global Vaccine Industry

Melanie Saville, MBBS, is PATH’s Chief Scientific Officer. She leads PATH’s product development division, which includes a global team dedicated to the development, introduction, and scale of vaccines, medical devices, and diagnostics. Dr. Saville is a Fellow of the Academy of Medical Sciences...

Dr. Kate O’Brien is the Director of the Immunization, Vaccines and Biologicals (IVB) Department at the World Health Organization (WHO). In this role she is responsible for leading WHO’s vaccine and immunization strategy and implementation to advance the vision of a world where...

As Chief Executive Officer of Hilleman Laboratories, a joint venture between Merck & Co and Wellcome Trust, Dr. Raman Rao leads the charge for providing effective, affordable and impactful solutions for infectious diseases and global public health, especially for low- and middle-income...

Dr. Florika Fink-Hooijer DIRECTOR-GENERAL, HEALTH EMERGENCY, PREPAREDNESS & RESPONSE AUTHORITY (DG HERA) Dr. Florika Fink-Hooijer leads the DG HERA in the European Commission. DG HERA’s primary mission is to counter vulnerabilities and strategic dependencies within the EU in relation to...

Dr. Veterinary Medicine, virologist, active in global networking in human and animal health, vaccines and diagnostics, global disease control, one health, public affairs with EU, WHO, Asian and African authorities and experienced in vaccine translational development. CV in brief: Research...

Michael C Caldwell MD MPH | Assoc VP Vaccine ResearchMeharry Medical College Michael C Caldwell, Assoc VP Vaccine Research, Meharry Medical CollegeDr. Caldwell is the Associate Vice President, Vaccine Research & Education at Meharry Medical College in Nashville TN.  He is Professor of Global...

Richard White is a Prof in Infectious Disease Epidemiology in the TB Modelling Group, TB Centre, Vaccine Center and Math Modelling Centre at the London School of Hygiene and Tropical Medicine. He was awarded a PhD in infectious disease modelling in 2006, led the establishment of the LSHTM’s Centre...

Dr. Luigi Buonaguro is the Director of the Innovative Immunological Models at the National Cancer Institute - IRCCS “Pascale ”, Naples – Italy. He is an expert in identification and characterization of tumor antigens for preventive/therapeutic cancer vaccine development. His focus is mostly on...

Dr Bassam Hallis OBE is the Deputy Director and the lead for the Vaccine Development and Evaluation Centre. Bassam has over 35 years’ experience working with public sector, industry and academia in the development and evaluation of vaccines and therapeutics. He provides scientific and operational...

Stephen Lockhart DM, FFPM, FMedSci. I qualified in Medicine from the University of Oxford in 1980.  After working around the UK in hospital medicine and research, I joined the pharmaceutical industry in 1986.  For over 30 years I have been engaged in global vaccine clinical R&D in...

Hanneke Schuitemaker, Ph.D., is the Chief Scientific Officer at Valneva, Austria, with responsibility for pre-clinical and translational R&D for prophylactic vaccines against infectious diseases. Before joining Valneva, she served for almost 14 years as the Head of Viral Vaccine Discovery and...

Nico Vandaele obtained a PhD in Business Engineering, Operations Management and Operations Research in 1996. Being a professor at KU Leuven since then, his research focus was on (bio-pharma) supply chains. In the last decade, the focus was on embedding the supply chain in broader health...

Dr. Ligia Pinto is the director of the Vaccine, Immunity and Cancer Directorate at the Frederick National Laboratory. She has worked in the area of immunology of infectious diseases, cancer and vaccines for the last 38 years, with over 200 peer-reviewed publications. She completed her Ph.D. in...

Pete joined LifeArc from Wellcome in Sep 2024 as Scientific Director in the Global Health team.  He's an Immunologist with >20 years in the life sciences, >12 years bridging R&D across academia and Industry and 8 years strategy, public/private partnerships and portfolio investment in...

Anja Schreijer is a medical specialist in infectious disease control who has worked for various national and international governments, WHO and ECDC. During the Covid-19 pandemic, she chaired the National Consultation on Infectious Disease Control, which was responsible for making scientifically...

As Professor in molecular virology my R&D focus is on the design, development and deployment of viral pseudotype based neutralisation assays for influenza, coronavirus and other emerging viruses, and I have received funding from the MRC, the Bill & Melinda Gates Foundation, Innovate UK, the ...

Dr. Ofer Levy was born to and raised by the artist Benjamin Levy and music composer Hannah Levy in New York City, where he graduated from the Bronx High School of Science. After graduating from Yale College (B.S., Molecular Biophysics and Biochemistry), Dr. Levy entered the Medical Scientist...

Dr. Alessandro Manenti graduated in Biology obtaining his Bachelor’s Degree in 2009 and a Master’s Degree in Molecular Evolution in 2013 at the University of Siena. He worked for six months in a big company in the field of Life Sciences (Novartis). In November 2013, he won a competition for PhD...

Meta Roestenberg is an infectious diseases clinician, professor in Human Models for Vaccine Development at Leiden University Medical Center in the Netherlands. She is head of the Leiden University Center for Infectious Diseases (LUCID), a large department with 400+ employees tasked with the...

Teresa Lambe is the Calleva Head of Vaccine Immunology and a Professor of Vaccinology & Immunology at the University of Oxford. She is leading a research group which improves human health by controlling disease through vaccination – stopping epidemics before they become pandemics. Prof Lambe is ...

Miguel Prudêncio completed his PhD by the University of East Anglia (UK) in 2000, followed by a post-doctoral period at the University of Leiden (NL). In 2004, he initiated his research careeer in the field of malaria, at Instituto de Medicina Molecular (iMM, PT), now the Gulbenkian Institute for...

Keira Cohen, MD, is an Executive Medical Director in Communicable Diseases at Johnson & Johnson Innovative Medicine.  She received her medical degree from the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania, and completed both Internal Medicine residency and...

Mats Lundgren, PhDChief Scientific OfficerAbera Bioscience AB   Dr. Mats Lundgren is a leading authority in vaccine discovery and development, with over 30 years of experience in the biopharmaceutical industry. His diverse background encompasses a wide range of roles, from scientist to vice...

Simona Rondini is the Head of Bacterial Vaccine Development and Senior Project leader at GSK Vaccines Institute for Global Health (GVGH) in Siena (Italy). Simona holds a PhD in Microbiology awarded by the Swiss Tropical Public Health Institute in Basel, and conducted postdoctoral studies at the...

Ruxandra Draghia-Akli, MD, PhD, is the Executive Vice President and Head of Research & Development (R&D) at Novavax with the responsibility of evaluating opportunities for its early and late-stage pipeline, ensuring the company is maximizing the tremendous potential of Novavax’s proven...

Rebecca Fish has over 30 years of senior leadership experience in the health sector, with a particular focus on vaccines and biodefense. She served as Senior Vaccine Policy Advisor to the U.S. Deputy Assistant Secretary of Health at the U.S. Department of Health and Human Services, where she...

Pascal Geldsetzer is an Assistant Professor of Medicine at Stanford University and a Biohub Investigator. His research focuses on identifying and evaluating the most effective interventions for improving health at older ages. In addition to leading several randomized trials, his methodological...

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring...

Dr. Jinte Middeldorp is a neuroscientist and Head of Department at the Biomedical Primate Research Centre (BPRC), where she leads research on brain aging, neuroinflammation, and the interaction between infectious diseases and the nervous system. Her work focuses on understanding how systemic...

Mónica works as Advocacy and Policy Director at GSK's CMC Global Regulatory Affairs. She is a medical biologist by training and holds a MSc in Molecular Biology and a PhD in Bioscience Engineering. Monica has over 19 year's experience in the pharmaceutical sector where she has held...

Jarno Robin, serves as Pharma Business Development Director at Sani Membranes where he is responsible for identifying new opportunities for Vibro® Membrane Filtration (VMF) Technology in pharmaceutical applications and setting up collaborations with industrial partners and universities to publish...

Anna Saernefaelt is a seasoned professional in the field of vaccine development and manufacturing, currently serving as Global Chemistry, Manufacturing, and Controls (CMC) Lead at the Coalition for Epidemic Preparedness Innovations (CEPI). With over 25 years of experience in the pharmaceutical and...

Hamid Trimech is a talented process engineer passionate about vaccine manufacturing.  For over 8 years in the vaccine industry, Hamid has led numerous projects involving the design, construction, and qualification of drug substance manufacturing facilities. Throughout his activities, he has...

Sebastian Ulbert is a molecular biologist specialized in immunology and infectious disease research. He is deputy director of the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig (Germany) and part of the Fraunhofer Society, Europe´s largest organization for applied...

Saul Walker is the Director of Public Partnerships at CEPI, leading collaboration with international and regional partners to advance shared objectives on rapid vaccine development and equitable access for emerging epidemic and pandemic pathogens. He also works to ensure CEPI’s develops respectful...

Gavin graduated from the University of Oxford with a degree in Biochemistry in 1996 before studying for a D.Phil. within the Medical Research Council (MRC) Cellular Immunology Unit with Professor Neil Barclay at the Sir William Dunn School of Pathology. He initially worked on CD200 (formally...